Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.0820
-0.0010 (-1.20%)
Aug 21, 2026, 4:11 PM AEST
Imugene Market Cap
Imugene has a market cap or net worth of 40.16 million as of August 21, 2026. Its market cap has decreased by -48.45% in one year.
Market Cap
40.16M
Enterprise Value
31.00M
Revenue
3.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 40.16M, an increase of 444.22%. That is a compound annual growth rate of 7.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 40.16M | -65.31% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amplia Therapeutics | 74.43M |
| Avecho Biotechnology | 73.41M |
| Entropy Neurodynamics | 61.19M |
| Botanix Pharmaceuticals | 54.69M |
| Radiopharm Theranostics | 52.05M |
| Neurizon Therapeutics | 46.51M |
| Nexsen | 44.04M |
| Argenica Therapeutics | 26.98M |